BRIEF published on 05/13/2026 at 07:48, 3 months 15 days ago Rapport de performance financière de Dermapharm Holding SE pour le premier trimestre 2026 Résultats Financiers Acquisitions Croissance Des Revenus Médicaments De Marque Confirmation Des Directives
PRESS RELEASE published on 05/13/2026 at 07:43, 3 months 15 days ago Dermapharm Holding SE performs in line with projections in Q1 2026 and confirms guidance Dermapharm Holding SE reports Q1 2026 results: 1.1% revenue growth to EUR 305.8 million, EBITDA up 7.5% to EUR 87.4 million. Confirms guidance for 2026 EBITDA Revenue Growth Dermapharm Holding SE Q1 2026 2026 Guidance
BRIEF published on 03/31/2026 at 07:35, 4 months 28 days ago Dermapharm Holding SE prévoit des résultats financiers mitigés en 2025 Baisse Des Revenus Augmentation De L'EBITDA Croissance Des Produits Pharmaceutiques De Marque Stabilité Des Produits De Santé Dépôt D'importation Parallèle
BRIEF published on 03/31/2026 at 07:35, 4 months 28 days ago Dermapharm Holding SE sees mixed financial outcomes in 2025 Revenue Decline EBITDA Increase Branded Pharmaceuticals Growth Healthcare Products Stability Parallel Import Drop
PRESS RELEASE published on 03/31/2026 at 07:30, 4 months 28 days ago Dermapharm Holding SE reports dip in revenue, rise in adjusted consolidated EBITDA and margin Dermapharm Holding SE reports dip in revenue but rise in adjusted consolidated EBITDA and margin for the 2025 financial year, with expectations of further growth in 2026 Adjusted EBITDA Dermapharm Holding SE Revenue Dip Financial Year 2025 Margin Rise
BRIEF published on 03/26/2026 at 20:53, 5 months 1 day ago Dermapharm Executes Share Buyback Amid Strong Interest Share Buyback Financial Management Treasury Shares Stock Market Dermapharm
BRIEF published on 03/26/2026 at 20:53, 5 months 1 day ago Dermapharm procède à un rachat d'actions face à un fort intérêt Rachat D'actions Marché Boursier Gestion Financière Dermapharm Actions Du Trésor
PRESS RELEASE published on 03/26/2026 at 20:48, 5 months 1 day ago Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer. Company's buyback program exceeded maximum shares tendered. Offer price to be available by 2 April 2026 Share Buyback Treasury Shares Public Offer Dermapharm Holding SE Stock Repurchase
BRIEF published on 03/10/2026 at 09:16, 5 months 18 days ago Dermapharm Holding SE Announces Share Buyback Offer Share Buyback Dermapharm Holding SE Capital Measures 4,300,000 Shares EUR 42.00 Per Share
BRIEF published on 03/10/2026 at 09:16, 5 months 18 days ago Dermapharm Holding SE annonce une offre de rachat d'actions Rachat D'actions Dermapharm Holding SE Mesures De Capital 4 300 000 Actions 42,00 EUR Par Action
Published on 08/28/2026 at 08:05, 3 hours 50 minutes ago Caledonia Mining Corporation Plc: Maiden Mineral Resource Estimate at Motapa 379,000 oz Measured and Indicated; 131,000 oz Inferred
Published on 08/28/2026 at 08:05, 3 hours 50 minutes ago Tocvan Announces New Surface Mineralization in Several Zones at Gran Pilar Gold-Silver Project
Published on 08/28/2026 at 08:00, 3 hours 55 minutes ago Caledonia Mining Corporation Plc: Blanket Mine Underground Measured and Indicated Mineral Resources Estimate Increases by 22% to 2.18 Million Ounces and Declaration of a Surface Mineral Resource Estimate
Published on 08/28/2026 at 04:30, 7 hours 25 minutes ago Snipp Interactive Reports Q2 2026 Financial Results; Returns to Positive EBITDA on Highest Quarterly Revenue in Five Quarters
Published on 08/27/2026 at 23:05, 12 hours 50 minutes ago Galway Metals Announces Filing of NI 43-101 Technical Report for Updated Clarence Stream Mineral Resource Estimate
Published on 08/28/2026 at 11:15, 40 minutes ago Redcare Pharmacy announces Managing Board succession: Peter Schmid von Linstow to succeed Olaf Heinrich as part of a planned leadership transition.
Published on 08/28/2026 at 11:12, 42 minutes ago EQS-Adhoc: Redcare Pharmacy N.V.: Change in the Managing Board; Peter Schmid von Linstow to become Chief Executive Officer.
Published on 08/28/2026 at 11:00, 55 minutes ago Warren Wise Unravels the Rheinmetall Paradox – Defense Boom Without a Share Price Rally
Published on 08/28/2026 at 10:58, 56 minutes ago High approval at the Annual General Meeting – Shareholders confirm the course of Netfonds AG
Published on 08/26/2026 at 18:02, 1 day 17 hours ago Altareit: Altarea press release regarding the Primonial matter
Published on 08/26/2026 at 18:02, 1 day 17 hours ago Altareit : Communiqué de presse d’Altarea relatif au dossier Primonial
Published on 08/26/2026 at 18:00, 1 day 17 hours ago Altarea: Comprehensive settlement agreement reached, ending the dispute between Altarea and the shareholders of the Praemia group (formerly Primonial group)
